Sector valuations Dr. Lal PathLabs Limited
Stocks
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,692.50 INR | -0.05% |
|
-3.11% | +14.02% |
| 06-17 | Dr. Lal PathLabs' Volume Boom Comes at a Cost | |
| 05-04 | Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 48.06x | 10x | 3.02x | 8.54x | 30.34x | 37.87x | 1.08% | 2.93B | ||
| -157.68x | 19.91x | -16.46x | 13.07x | -177.98x | -143.71x | -.--% | 37.61B | ||
| 19.4x | 2.45x | 0.5x | 1.88x | 10.85x | 12.8x | 1.04% | 23.08B | ||
| 17.47x | 1.22x | 1.07x | 1.35x | 7.68x | 14.06x | 5.01% | 7.5B | ||
| 311.18x | - | -1.75x | - | - | - | - | 4.77B | ||
| -31.95x | - | 0.68x | - | - | - | -.--% | 1.85B | ||
| -18.13x | - | -0.05x | - | - | - | - | 1.8B | ||
| 32.55x | 1.77x | -0.1x | 1.62x | 12.36x | 19.51x | 1.57% | 1.83B | ||
| 13.02x | 1.74x | 0.96x | 1.34x | 5.26x | 8.98x | 5.81% | 1.77B | ||
| 28.67x | 1.74x | 0.04x | 1.11x | 8.6x | 12.6x | 0.86% | 1.68B | ||
| 80.16x | 14.4x | 4.09x | 16.68x | 41.19x | 56.16x | 0.13% | 1.42B | ||
| 59.44x | 8.19x | 1.6x | 7.12x | 29.36x | 42.45x | 0.35% | 1.23B | ||
| 32.95x | 1.38x | -2.14x | 0.81x | 6.7x | 22.92x | 3.69% | 1.15B | ||
| -3.96x | 0.52x | -3.97x | 0.96x | - | -2.44x | - | 906M | ||
| 45.01x | 13.85x | 2.2x | - | - | - | 1.94% | 916M | ||
| 18.06x | 1.04x | -14.2x | - | - | - | 3.44% | 837M | ||
| 24.85x | 1.87x | 0.97x | - | - | - | 0.39% | 766M | ||
| -42.03x | - | 1.41x | 177.25x | -38.66x | -36.71x | - | 586M | ||
| Average | 26.50x | 5.72x | -1.23x | 19.31x | -5.85x | 3.71x | 1.81% | 5.15B | |
| Weighted average by Cap. | -36.86x | 10.77x | -6.51x | 8.76x | -76.38x | -57.35x | 1.05% |
- Stock Market
- Stocks
- LALPATHLAB Stock
- Sector Dr. Lal PathLabs Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















